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OBJECTIVE — Finding the anthropometric measure of visceral obesity is essential to clinical
practice, because it predicts cardiovascular and metabolic risks. Sagittal abdominal diameter
(SAD) has been proposed as an estimate of visceral adipose tissue (VAT). The aim of the present
study was to evaluate the usefulness of SAD in predicting visceral obesity by comparing SAD to
other anthropometric measures.
RESEARCH DESIGN AND METHODS — Estimation of subcutaneous and visceral
adipose tissue and measurement of SAD and transverse abdominal diameter using computed
tomographyattheumbilicallevelwereobtainedin5,257menandwomenwhowereenrolledin
a health checkup program in Korea. To compare SAD to other anthropometric measures, linear
regression analyses were used to determine correlations between anthropometrics and visceral
obesity.
RESULTS — SAD showed a stronger correlation to VAT than waist circumference, BMI, and
transverse abdominal diameter in the both sexes (men: r  0.804, women: r  0.724). Waist
circumferenceshowedgenerallystrongerassociationstosubcutaneousadiposetissue(SAT)than
to VAT (men: r  0.789 vs. 0.705, women: r  0.820 vs. 0.636). Even after subdividing
according to age or BMI in both sexes and analyzing multiple regressions, SAD showed the
strongest correlation to VAT.
CONCLUSIONS — SAD showed the strongest correlation to VAT irrespective of age, sex,
andthedegreeofobesitycomparedwithotheranthropometricmeasures,whereaswaistcircum-
ference may have a stronger correlation to SAT than to VAT. The clinical use of SAD has
advantages over other anthropometric measures in predicting VAT.
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lthough abdominal obesity has
been considered a risk factor com-
promising health in only Western
countries, where its presence has been
relatively high, the prevalence of abdom-
inal obesity has recently increased in
Asian countries because of sedentary life-
styles and westernized diet. Abdominal
obesity frequently leads to diabetes or
metabolic disorders and can induce car-
diovascular diseases with a risk of early
death (1,2). Several studies have sug-
gestedthat,comparedwithsubcutaneous
adipose tissue (SAT), visceral adipose tis-
sue (VAT) has a stronger correlation to
these obesity-related disorders (3,4).
Thus,accuratemeasurementofVATisre-
quired to predict the risk of obtaining
such diseases. Computed tomography
(CT) or magnetic resonance imaging is
the most accurate method for estimating
VAT (5). However, since the high costs of
these tests make them clinically impracti-
cal, much effort has been made to ﬁnd
inexpensive, easily obtainable anthropo-
metric measures to clinically evaluate the
relationship between VAT and metabolic
diseases.
Waist circumference (WC) has been
widely used to measure abdominal obe-
sity (6), and it serves as one of the criteria
for the diagnosis of metabolic syndrome
(7,8). However, WC does not distinguish
visceral from subcutaneous abdominal
adipose tissue (9–11). Pou et al. (11) re-
vealed that WC may misclassify individ-
uals in terms of VAT. Their result implies
that other anthropometric measures to
correlate with VAT are needed.
Sagittal abdominal diameter (SAD),
which measures the anteroposterior di-
ameter of the abdomen, reﬂects VAT
based on the fact that subcutaneous fat is
displaced inferiorly by gravity (12). Since
SAD was introduced as a means of esti-
mating visceral obesity (12), a few studies
have been conducted on the usefulness of
SAD in the evaluation of visceral obesity
(13–15) as well as cardiovascular and
metabolic risks (16,17) in comparison to
other anthropometric measures. How-
ever, there were still insufﬁcient evi-
dences to draw any conclusions whether
SAD more accurately represents visceral
obesity due to the small number of sub-
jects and selection process in the previ-
ous studies. Larger population-based
studies are still needed to determine it.
Moreover, the previous studies on SAD
have been carried out in Western coun-
tries; there have been little data in the
Asian population.
Transverse abdominal diameter
(TAD) was the largest spanned width,
whereas SAD was the largest spanned
height of the abdomen (12). TAD has
been presented on correlation to SAT
(12,13,15).However,TADhasneverpre-
viously been investigated in terms of its
correlation to the amount of adipose tis-
sue in the Asian population.
Therefore,thepresentstudywascon-
ducted to compare SAD to other anthro-
pometric measures in predicting the
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a large, apparently healthy population.
RESEARCH DESIGN AND
METHODS— The study population
consisted of 5,257 men and women who
were enrolled retrospectively in a health
checkup program from March 2007 to
December 2008 at the Seoul National
University Hospital Healthcare System
Gangnam Center. They were mostly free
of symptoms and voluntarily underwent
an abdominal CT scan with the blood
samplingsforlaboratorydeterminantsin-
cluding serum lipid proﬁles, fasting glu-
cose, and A1C as part of their exam. All
subjectshadtheirbloodpressurechecked
twice and were asked to answer question-
naires under the supervision of a well-
trained interviewer. Current smoker was
deﬁned as smoking at least one cigarette
perdayinthepreviousyear.Alcoholcon-
sumption was dichotomized on the basis
of 140 g/week. Women were consid-
ered menopausal if periods had stopped
over 1 year. The questionnaire included
questions regarding the medical and sur-
gical histories. The subjects who had ex-
perienced prolonged bed rest in the
previous year or recent weight changes
and who had undergone abdominal sur-
gery in the past were excluded. The sub-
jects with malignancy or chronic liver
disease with ascites were also excluded. A
total of 5,100 subjects were ﬁnally en-
rolled in this study. The subjects were
classiﬁed by age within each sex (50 or
50 years). This study protocol con-
formed to the ethical guidelines of the
1975 Declaration of Helsinki and was ap-
provedbytheInstitutionalBoardofSeoul
National University Hospital.
Anthropometric measurements
Anthropometric measurements were per-
formed on subjects wearing light hospital
gowns without shoes. Body weight was
measured to the nearest 0.1 kg, and
height was assessed to the nearest 0.1 cm
by using a wall-mounted stadiometer.
BMI was calculated by dividing weight
(kg) by the square of height (m
2) catego-
rized as follows: normal to overweight
group (BMI 25 kg/m
2) and obese group
(BMI 25 kg/m
2). With the subject in a
standing position, the WC was taken at
the midline between the lower border of
the rib cage and iliac crest to the nearest
0.1 cm after a normal expiration.
Measurement of adipose tissue areas
and SAD by CT
Measurementofabdominaladiposetis-
sue areas. The technique used for adi-
pose tissue area measurements in CT
cross-sectional images has been previ-
ously described (18). Brieﬂy, the subjects
wereexaminedwitha16-detectorrowCT
scanner(SomatomSensation16;Siemens
Medical Solutions, Forchheim, Germany)
in a supine position. The area was mea-
sured with commercially available CT
software (Rapidia 2.8; INFINITT, Seoul,
Korea), which electronically determined
the adipose tissue area by setting the at-
tenuation values for a region of interest
within a range of 250 to 50 House-
ﬁeld units.
Measurement of SAD and TAD. SAD
was determined via an electronic mea-
surement using the umbilical CT image,
with the cursor extending from skin to
skinthroughthecenteroftheabdomenin
the anterior-posterior direction. TAD was
deﬁnedasthelargestspannedwidthfrom
skin to skin through the center of the ab-
domen in both lateral directions in the
same image. These measurements were
determined to the nearest 0.1 cm.
Statistical analyses
Statistical analyses were conducted sepa-
rately for men and women because of
known differences in adiposity. Data are
presented as means and SDs. To compare
differences between sex groups, the Stu-
dentttestandMann-WhitneyUtestwere
performed. Age-adjusted correlation co-
efﬁcients between the abdominal adipose
tissue compartments (SAT and VAT) and
theanthropometricmeasures(SAD,TAD,
BMI, and WC) were calculated for each
group. The independent relationship be-
tween anthropometric measures and ab-
dominal adipose tissue compartment was
examined by multiple regression analysis
and determination of the standardized
correlation coefﬁcients. In the multiple
regression models, we included addi-
tional variables with a known or probable
association with abdominal obesity, such
asage,smoking,alcohol,diabetes,hyper-
lipidemia,medicationhistory,andmeno-
pausal status. Analyses were performed
using the Statistical Package for the Social
Sciences (version 12.0; SPSS, Chicago,
IL). A two-tailed P value of 0.05 was
considered statistically signiﬁcant.
RESULTS— Clinical characteristics of
the enrolled population are presented in
Table 1. The mean age of this population
was 51.1  9.6 years and 63.9% were
men. Table 2 gives correlations adjusted
for age and additional variables between
anthropometric measures and adipose
tissue compartments in each sex. All an-
thropometric measures were statisti-
cally correlated to VAT and SAT in both
sex groups. Compared with other vari-
ables,SADwasmorestronglycorrelated
to VAT in both sexes (men: r  0.804,
women: r  0.724). In contrast, WC
showed stronger correlations to SAT
than to VAT in all groups. Particularly
in women, TAD showed a statistically
stronger correlation to SAT than the
correlation of WC to SAT.
We divided the total population into
youngerandolderage-groupsusinga50-
year-oldcutoffpoint,andanthropometric
and adipose tissue characteristics of the
subject are presented in Table 3. All vari-
ableswerestatisticallysigniﬁcantlyhigher
in the older women than in the younger
women. In contrast, the older men had
statistically signiﬁcantly more VAT but
less SAT than the younger men, and only
TAD and BMI were signiﬁcantly lower in
the older men, like SAT. Table 4 shows
the correlations between anthropometric
measures and adipose tissue compart-
ments according to age in both sex
groups. SAD was presented the highest
correlation coefﬁcients for VAT in both
sexes and in both age-groups, whereas
WC showed stronger correlations with
SAT than with VAT. The correlations of
anthropometric measures to adipose
tissue after subdividing into two groups
on the basis of BMI within both sexes
are shown in Table 5. SAD showed the
strongest correlation to VAT in both
normal/overweight and obese groups
within both sexes. In addition, WC was
more highly correlated to SAT than to
VAT in all the subgroups. TAD showed
a stronger correlation to SAT than the
correlation of WC to SAT in all sub-
groups of women.
CONCLUSIONS — The aim of the
present study was to evaluate the useful-
ness of SAD in predicting visceral obesity
bycomparingSADtoWC,BMI,andTAD.
TheresultsshowedthatSADstronglycor-
relatedtoVATirrespectiveofage,sex,the
degree of obesity, and other metabolic
risks compared with other anthropomet-
ric measures.
SAD reﬂected VAT most accurately in
all subjects and both sex groups. Van der
Kooy et al. (13) reported that SAD more
strongly correlated with VAT in men,
SAD as a predictor of VAT
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withVATinwomen.However,otherpre-
vious studies have demonstrated that
SAD has a stronger correlation with VAT
in women (14,15). It is well known that
visceral adiposity increases with age (9).
We conﬁrmed that the older men and
women had signiﬁcantly more VAT than
the younger group. In the present study,
the highest correlations among the four
anthropometric measures in both women
50 years and 50 years were found be-
tween SAD and VAT. SAD was also supe-
rior to other measures in predicting
visceral obesity in men 50 years as well
as men 50 years. In other words, SAD
was well correlated with VAT in both the
younger and older groups, as demon-
stratedinpreviousstudies(15).Whenthe
subjectsweredividedaccordingtothede-
gree of obesity, SAD showed a consis-
tently stronger correlation with visceral
obesity compared with other measures in
both the normal/overweight and obese
groups; this result was similar to previous
studies, which found that SAD predicted
VAT in subjects with a wider range of
BMIs (12).
WC, on the other hand, showed a
stronger correlation with SAT than with
VAT in both sexes, which was similar to
previous studies (3,15,19). We also
showed the same results even after subdi-
viding according to age or BMI. Although
WC is an easily obtainable index of ab-
dominal obesity, it has not shown any su-
periority to SAD in the correlation with
VAT. Since Kvist et al. (12) proposed the
usefulnessofSADintheevaluationofvis-
ceral obesity, there have been a few stud-
Table 2—Sex-speciﬁc age-adjusted and multivariable-adjusted standardized correlation co-
efﬁcients between anthropometric measures and adipose tissue compartments
Men (n  3,259) Women (n  1,841)
VAT SAT VAT SAT
SAD
Age-adjusted 0.804 0.687 0.724 0.724
Multivariable-adjusted 0.798 0.691 0.716 0.732
TAD
Age-adjusted 0.693 0.742 0.613 0.857
Multivariable-adjusted 0.687 0.744 0.602 0.861
BMI
Age-adjusted 0.639 0.734 0.617 0.742
Multivariable-adjusted 0.630 0.738 0.606 0.753
WC
Age-adjusted 0.705 0.789 0.636 0.820
Multivariable-adjusted 0.698 0.796 0.626 0.830
All correlations were statistically signiﬁcant (P  0.001). Data were multivariable adjusted for age, smoking,
alcoholconsumption,diabetes,hyperlipidemia,treatmentfordiabetes,treatmentforhyperlipidemia,meno-
pausal status (women only), and hormone replacement therapy (women only).
Table 1—Clinical characteristics of the study population
Total Men Women
n 5,100 3,259 1,841
Age (years) 51.1  9.6 (26–84) 51.0  9.6 (26–84) 51.3  9.6 (26–80)
Diabetes (%) 7.5 9.6 3.9*
Diabetes medication (%) 6.0 7.7 3.1*
Hypertension (%) 20.8 23.5 16.2*
Hypertension medication (%) 17.5 19.7 13.5*
Smoking (%)
Current 30.7 45.4 4.7*
Former 22.2 32.5 3.8*
Never 47.1 22.1 91.5*
Alcohol consumption (%) 19.9 29.9 2.2*
Postmenopausal (%) 51.1
Hormone replacement therapy (%) 11.8
BMI (kg/m
2) 23.97  3.00 (14.3–42.0) 24.81  2.70 (15.5–42.0) 22.49  2.92 (14.3–36.9)*
Waist circumference (cm) 85.79  8.14 (61.0–129.0) 88.18  7.21 (61.0–129.0) 81.57  7.97 (61.0–118.0)*
Systolic blood pressure (mmHg) 117.5  14.3 (74–186) 119.5  13.4 (83–186) 113.7  15.2 (74–163)*
Diastolic blood pressure (mmHg) 75.9  11.4 (36–120) 78.5  10.7 (46–120) 71.3  11.1 (36–113)*
Total cholesterol (mg/dl) 193.0  34.0 (88–393) 192.1  33.8 (88–321) 194.7  34.2 (98–393)*
Triglycerides (mg/dl) 119.7  76.9 (32–1,222) 134.9  84.4 (32–1,222) 92.7  51.6 (32–863)*
HDL cholesterol (mg/dl) 53.1  13.7 (18–128) 49.4  12.1 (18–128) 59.6  14.1 (26–126)*
Lipid-lowering medication (%) 7.7 8.4 6.5†
Fasting glucose (mg/dl) 97.1  20.2 (56–330) 100.5  21.8 (61–330) 91.1  15.2 (56–260)*
A1C (%) 6.00  0.72 (4.1–13.4) 6.03  0.80 (4.1–13.4) 5.94  0.56 (4.6–12.6)*
VAT (cm
2) 118.0  55.2 (6.03–445.59) 137.7  51.9 (6.03–445.59) 83.2  42.2 (10.40–269.31)*
SAT (cm
2) 152.5  61.6 (7.30–617.79) 139.4  54.6 (7.30–617.79) 175.8  66.1 (17.43–483.97)*
SAD (cm) 21.5  3.0 (12.61–34.12) 22.6  2.4 (14.53–34.12) 19.3  2.4 (12.61–29.95)*
TAD (cm) 30.7  2.8 (21.71–45.28) 31.4  2.5 (21.94–45.28) 29.6  3.1 (21.71–41.48)*
Data are means  SD (range) unless otherwise indicated. *P  0.001 men vs. women; †P  0.05 men vs. women.
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VAT measured by CT or MRI (13–15).
However, besides the small number of
study subjects, these studies were lim-
ited in that the subjects were not of the
general population, because they had
enrolled for weight loss treatment (13)
or volunteered to participate in other
studies (15). The present large-scale,
population-based study evaluated SAD
by comparing it with WC as a measure
of VAT, and we suggest that SAD is a
more reliable index of VAT.
According to the anthropometric
characteristics of the younger and older
age-group in our study, the older men
had less SAT and the older women had
more SAT. SAT has been reported to de-
crease with age in men (11), but age-
related changes of SAT in women are
unclear because some studies have re-
ported the same results with ours (20),
whereas others have not (21). Our data
demonstrate that WC and TAD reﬂect
SAT in men and women, respectively.
BMI did not reﬂect regional body fat
distribution (22). We were also not able
to ﬁnd any stronger correlations between
BMI and VAT or SAT than other anthro-
pometricmeasures.Regionalbodyfatdis-
tribution differs according to ethnicity
(10). Although Asians show lower BMI
values than Westerners, they have been
shown to have a higher percentage of
body fat (23). Furthermore, it has been
documented that, in subjects with the
same WC, Asians have more VAT than
Western people (10). For these reasons,
the World Health Organization Asia-
Paciﬁc Region recommended to modify
WC criteria to apply to the Asian popula-
tion (8). Consequently, each country
measured WC and decided its cutoff
value for VAT, but the values were too
variable to draw an acceptable conclu-
sion, even in the same country (23–25).
The reason for this result may be that WC
is inappropriate for evaluating VAT in
Asians, whose regional body fat distribu-
tionisdifferentfromthatofindividualsof
the Western population.
Strengths of our study include our
samplesize,whichislarge,evenaftersub-
dividingtoexploredifferencesamongage
and BMI. Also, the data collected were
measurements obtained by trained per-
sonnel with a systematic protocol, not
self-reported measurements. Impor-
tantly, based on a screening policy, the
subjects in this study are generally re-
garded to be representative of the general
population.
The results of our study are subject
to limitation. SAD and TAD were not
measured directly; instead, SAD and
TAD were measured by CT scans. How-
ever, previous studies have shown that
SAD measured by anthropometry is an
excellent predictor of SAD measured by
a CT image (13,14). Also, because there
have been few studies within the Asian
population, our study has some clinical
implications that may introduce the
usefulness of SAD as an index of VAT in
Asians.
In conclusion, the results of the
present study showed that SAD has a
stronger correlation to VAT than BMI,
WC, and TAD, irrespective of age, sex,
and the degree of obesity, whereas WC
may have a stronger correlation to SAT
than to VAT. From a public health per-
spective, the clinical use of SAD has ad-
Table 3—Anthropometric and adipose tissue characteristics of younger and older age-groups
Men Women
Age 50 years Age 50 years Age 50 years Age 50 years
n 1,455 1,804 804 1,037
VAT (cm
2) 133.8  51.5 140.9  52.0* 64.3  33.9 97.9  42.2*
SAT (cm
2) 148.3  61.6 132.3  47.1* 154.6  59.0 192.2  66.7*
SAD (cm) 22.7  2.5 22.6  2.3 18.5  2.3 20.0  2.4*
TAD (cm) 31.7  2.6 31.2  2.4* 28.5  2.7 30.4  3.1*
BMI (cm) 25.05  2.93 24.62  2.48* 21.58  2.81 23.19  2.81*
WC (cm) 88.24  7.69 88.13  6.81 78.49  7.28 83.96  7.65*
Data are means  SD. *P  0.001, age 50 years group vs. age 50 years group.
Table 4—Sex-speciﬁc age-adjusted and multivariable-adjusted standardized correlation coefﬁcients between anthropometric measures and
adipose tissue compartments according to age in both sexes
Men Women
Age 50 years
(n  1,455)
Age 50 years
(n  1,804)
Age 50 years
(n  804)
Age 50 years
(n  1,037)
VAT SAT VAT SAT VAT SAT VAT SAT
SAD
Age-adjusted 0.807 0.732 0.805 0.661 0.785 0.732 0.741 0.715
Multivariable-adjusted 0.801 0.736 0.799 0.664 0.779 0.737 0.732 0.726
TAD
Age-adjusted 0.696 0.792 0.693 0.696 0.689 0.848 0.603 0.850
Multivariable-adjusted 0.692 0.793 0.685 0.698 0.685 0.851 0.589 0.855
BMI
Age-adjusted 0.643 0.768 0.637 0.712 0.712 0.764 0.621 0.738
Multivariable-adjusted 0.637 0.771 0.628 0.715 0.703 0.767 0.607 0.753
WC
Age-adjusted 0.708 0.829 0.713 0.757 0.706 0.813 0.622 0.797
Multivariable-adjusted 0.702 0.834 0.706 0.764 0.703 0.818 0.609 0.810
All correlations were statistically signiﬁcant (P  0.001). Data were multivariable adjusted for age, smoking, alcohol consumption, diabetes, hyperlipidemia,
treatment for diabetes, treatment for hyperlipidemia, menopausal status (women only), and hormone replacement therapy (women only).
SAD as a predictor of VAT
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